Recovery Inspired Support Engagement (RISE) Pilot
Mclean Hospital · with National Institute on Drug Abuse (NIDA) · NCT07519759
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 18
- US sites recruiting
- 1
- Study start
- September 14, 2026
- Record last updated
- September 15, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to learn if a 1-on-1 support program is easy to complete and acceptable for people supporting loved ones who have recently received treatment for substance use. The main questions it aims to answer are:
How many people complete the program? How satisfied are people with the program?
Participants will
Complete weekly telehealth sessions for 12 weeks Complete surveys/interviews at the beginning, in the middle (\~week 6), at the end of the program (\~week 12), and 12-weeks after the end of the program Complete a focus group or interview
Being studied: ITC
Conditions: Support Persons; Family Members; Chosen Family; Romantic Partners; Friends; Caregivers; Substance Use Disorders
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Inclusion Criteria for Support Persons:
- Ages 18+.
- Having a loved one who participated in an inpatient or residential substance use disorder program in the past 30 days, as reported by loved one, support person, clinician, or chart review.
- Interest in supporting the loved one's recovery from substance use.
- At least 4 days per month virtual or in-person contact per month with the loved one.
- Access to a computer with internet or mobile phone with video conferencing capabilities.
- Ability to provide written informed consent.
- Speak and read English.
- Inclusion Criteria for Loved Ones:
- Ages 18+.
- Participated in an inpatient or residential substance use disorder program in the past 30 days, as reported by self, support person, clinician, or chart review.
- At least 4 days per month virtual or in-person contact per month with the support person.
- Access to a computer with internet or mobile phone with video conferencing capabilities.
- Ability to provide written informed consent.
- Speak and read English.
Exclusion Criteria
- Exclusion Criteria for Support Persons:
- DSM-5 moderate or severe substance use disorder in the past year.
- History of domestic violence with the loved one that would interfere with the ability to safely follow through with the intervention plan.
- Psychiatric, cognitive, or medical impairments that would interfere with the ability to follow through with the intervention plan.
- Prior participation of a support person of the loved one in an ITC-related research study.
- Significant prior experience with ITC or CRAFT (e.g., having completed an ITC-related training workshop or course prior to study enrollment)
- Exclusion Criteria for Loved Ones: N/A
Recruiting US locations
McLean Hospital
Belmont, MA 02478
Site contact: Julie M McCarthy, PhD · 617-855-3521 · jmccarthy@mclean.harvard.edu
Study contacts (from the official record)
- Julie M McCarthy, PhD · 16178553521 · jmccarthy@mclean.harvard.edu
- Roger D Weiss, PhD · 617-855-2242 · rweiss@mclean.harvard.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+